blinatumomab 35 MCG Injection

RxCUI: 1597262
RxNorm name: blinatumomab 35 MCG Injection
Display name: blinatumomab 35 MCG Injection
Full name: blinatumomab 35 MCG Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:54

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125557	Blincyto	blinatumomab	351(a)	Rx	2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
BLINCYTO	BLINATUMOMAB	Amgen, Inc	38b482a8-960b-4591-9857-5031ecb830aa	2026-04-14	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1597262

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
38b482a8-960b-4591-9857-5031ecb830aa	blinatumomab 35 MCG Injection [PSN] · blinatumomab 0.035 MG Injection [SCD] · blinatumomab 35 MCG Injection [SY]	3	42	These highlights do not include all the information needed to use BLINCYTO ® safely and effectively. See full prescribing information for BLINCYTO. BLINCYTO ® (blinatumomab) for injection, for intravenous use Initial U.S. Approval: 2014	20260414